medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2009, Number 2

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2009; 22 (2)

Lung cancer and HIV infection. A case report and literature review

Reyes-Corch A, Sierra MDP, Sabatés-Llerandi T, Delgado-Pino F, Olivert-Cruz M, Díaz N

Language: English
References: 21
Page: 92-97
PDF size: 114.55 Kb.


ABSTRACT

Lung cancer (LC) is the third more frequent malignancy in human immunodeficiency virus-1 (HIV)-infected individuals. The first case of LC in a Cuban HIV-infected patient is presented. It was a squamous cell carcinoma at advanced stage (III-B) and the clinical evolution was unfavorable; however, the patient did not develop acquired immunodeficiency syndrome (AIDS)-related events. Most HIV-infected patients with LC are symptomatic at diagnosis, reflecting an advanced disease (stages III-B/IV) between 70 and 90% of cases. Adenocarcinoma is the most frequent histological type. LC represents a new challenge in HIV-infected population, so its prevention, early diagnosis, and management should be included in the long-term follow-up of this group of patients.


REFERENCES

  1. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst 2005;97:407-409.

  2. Galceran J, Marcos-Gragera R, Soler M, et ál. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007;43:1085-1091.

  3. Lewden C, Salmon D, Morlat P, et ál. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005;34:121-130.

  4. Irwin LE, Begandy MK, Moore TM. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:158.

  5. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS 2007;21:207-213.

  6. Lavolé A, Epaud C, Rosencher L, Gounant V, Wislez M, Cadranel J. Lung cancer in HIV-positive patients. Rev Pneumol Clin 2007;63:167-175.

  7. Engels EA, Pfeiffer RM, Goedert JJ, et ál; and for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654.

  8. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the Millennium. JAMA 2001;285:1186-1192.

  9. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007;167:335-342.

  10. Kirk GD, Merlo C, O’Driscoll P, et ál. HIV infection is associated with increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103-110.

  11. Cadranel J, Garfield D, Lavolé A, Wislez M, Milleron B, Mayaud C. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006;61:1000-1008.

  12. Barbaro G, Barbarini G. HIV infection and cancer in the era of highly active antiretroviral therapy (Review). Oncol Rep 2007;17:1121-1126.

  13. Newnham A, Harris J, Evans HS, Evans BG, Møller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005;92:194-200.

  14. Lavolé A, Massiani MA, Chouaid C, et ál. Lung cancer in Human Immunodeficiency Virus (HIV) infected-patients in the era of highly active antiretroviral therapy (HAART): a case control-study. Lung Cancer 2003; 41(Suppl 2):S110.

  15. Dufour V, Cadranel J, Wislez M, et ál. Changes in the pattern of respiratory diseases necessitating hospital ization of HIV-infected patients since the advent of highly active antiretroviral therapy. Lung 2004;182: 331-341.

  16. Jasmer RM, Edinburgh KJ, Thompson A, et ál. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients. Chest 2000;117:1023-1030.

  17. Lavolé A, Wislez M, Antoine M, Mayaud C, Milleron B, Cadranel J. Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 2006;51:1-11.

  18. Biggar RJ, Engels EA, Ly S, et ál. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005;39:293-299.

  19. Bonnet F, Burty C, Lewden C, et ál; and Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group. Changes in cancer mortality among HIV-infected patient: the Mortalité 2005 survey. Clin Infect Dis 2009;48:633-639.

  20. Monforte A, Abrams D, Pradier C, et ál; and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008;22:2143-2153.

  21. d’Arminio Monforte A. Malignancy-related deaths among HIV-infected patients. Clin Infect Dis 2009;48: 640-641.




2020     |     www.medigraphic.com